MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
6.93
+0.07 (1.02%)
Dec 5, 2025, 4:00 PM EST - Market closed
MiMedx Group Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for MiMedx Group stock has a target of 12, which predicts a 73.16% increase from the current stock price of 6.93.
Price Target: $12.00 (+73.16%)
Analyst Consensus: Buy
* Price targets were last updated on Jul 31, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for MiMedx Group is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $11 → $12 | Buy | Maintains | $11 → $12 | +73.16% | Jul 31, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +58.73% | Jul 15, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $13 | Buy | Reiterates | $13 | +87.59% | Feb 27, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $11 | Buy | Reiterates | $11 | +58.73% | Aug 1, 2024 |
| Craig-Hallum | Craig-Hallum | Strong Buy Maintains $14 → $12 | Strong Buy | Maintains | $14 → $12 | +73.16% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
415.63M
from 348.88M
Increased by 19.13%
Revenue Next Year
424.40M
from 415.63M
Increased by 2.11%
EPS This Year
0.43
from 0.28
Increased by 51.47%
EPS Next Year
0.25
from 0.43
Decreased by -41.67%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 432.2M | 488.2M | ||||
| Avg | 415.6M | 424.4M | ||||
| Low | 392.0M | 370.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 23.9% | 17.4% | ||||
| Avg | 19.1% | 2.1% | ||||
| Low | 12.4% | -10.9% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.46 | 0.30 | |
| Avg | 0.43 | 0.25 | |
| Low | 0.39 | 0.20 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 63.4% | -28.9% | |
| Avg | 51.5% | -41.7% | |
| Low | 38.6% | -54.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.